Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced the acquisition of Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals, Inc.
The details can be read here.
No comments:
Post a Comment